High Tech Pharm Co., Ltd. (KOSDAQ:106190)

High Tech Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	130,044	148,864	99,208	77,268	97,116	130,788
Market Cap Growth	-23.71%	50.05%	28.39%	-20.44%	-25.75%	63.27%
Enterprise Value	117,228	153,628	111,271	89,346	110,402	138,335
Last Close Price	12230.00	14000.00	9263.36	7164.94	8948.68	12007.34
PE Ratio	10.85	10.86	12.28	13.16	-	-
PS Ratio	1.72	1.92	1.29	0.75	1.33	1.76
PB Ratio	1.02	1.24	0.93	0.77	1.03	1.38
P/TBV Ratio	1.02	1.24	0.93	0.77	1.03	1.38
P/FCF Ratio	7.09	11.85	-	-	16.00	-
P/OCF Ratio	6.33	10.13	34.11	-	14.02	-
EV/Sales Ratio	1.55	1.98	1.45	0.87	1.51	1.86
EV/EBITDA Ratio	6.57	7.41	7.38	8.53	21.49	64.99
EV/EBIT Ratio	9.39	9.88	11.03	18.13	-	-
EV/FCF Ratio	6.39	12.23	-	-	18.19	-
Debt / Equity Ratio	0	0.07	0.15	0.16	0.17	0.11
Debt / EBITDA Ratio	0.00	0.39	1.09	1.57	3.11	4.92
Debt / FCF Ratio	0.00	0.64	-	-	2.63	-
Asset Turnover	0.54	0.56	0.57	0.81	0.58	0.57
Inventory Turnover	1.70	1.92	3.18	5.88	3.86	5.13
Quick Ratio	2.44	1.48	1.31	1.15	0.97	0.77
Current Ratio	5.56	3.39	2.48	1.64	1.78	1.50
Return on Equity (ROE)	9.85%	12.09%	7.81%	6.06%	-1.30%	-3.25%
Return on Assets (ROA)	5.59%	7.07%	4.72%	2.41%	-0.21%	-1.60%
Return on Capital (ROIC)	6.09%	7.74%	5.26%	2.72%	-0.24%	-1.93%
Return on Capital Employed (ROCE)	9.80%	12.80%	9.00%	4.90%	-0.40%	-3.30%
Earnings Yield	9.21%	9.21%	8.14%	7.60%	-1.26%	-2.41%
FCF Yield	14.10%	8.44%	-2.20%	-5.64%	6.25%	-6.60%
Payout Ratio	8.88%	5.17%	6.14%	6.04%	-	-
Buyback Yield / Dilution	-	-49.99%	33.33%	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.